Cancer Stock Universe
Cancer has touched each of us. As investors, we can not only participate in the efforts to eliminate this horrible disease, but also, hopefully, make a few bucks too.
AB Analytical Services has undertaken a vast effort: Not only defining the universe of publicly-traded companies dedicated to fighting Cancer, but also providing the investor with enough information to narrow the list in order to focus on the names that deserve attention.
Below, you will find an example of one of the reports we have produced. While our initial cut yielded just under 90 companies with market capitalizaitons in excess of $50mm, we are sharing with you all of the "A" companies.
We are offering two different versions of the report, which can be delivered as an Excel file so that you can sort it according to your priorities.
The Standard version, which includes all of the names and several additional parameters (valuation, balance sheet, price performance over different time-frames) is available for $50 for a single issue or $120 for a quarterly subscription.
The Premium version, which provides additional data above the Standard version (short-interest, institutional ownership and additional valuation, balance sheet and price performance data), also includes a profile of two names each month. This report, produced monthly, is available by subscription only (first month free) for $1200 a year.
Contact firstname.lastname@example.org for more information.